Skip to content
healthcare.dev

A-25

NDC 58264-0317, GRINDELIA CILIATA POLLEN, DYSPHANIA BOTRYS POLLEN, XANTHIUM STRUMARIUM POLLEN, LEUCANTHEMUM VULGARE POLLEN, TARAXACUM OFFICINALE POLLEN, LONICERA JAPONICA FLOWER, IVA ANNUA POLLEN, ARTEMISIA VULGARIS POLLEN, and AMARANTHUS RETROFLEXUS POLLEN, solution, from DNA Labs, Inc..

Product NDC
58264-0317
Status
Listed
Labeler
DNA Labs, Inc.
Dosage form
SOLUTION
Route
SUBLINGUAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0317 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRINDELIA CILIATA POLLEN30 [hp_X]/mL
  • DYSPHANIA BOTRYS POLLEN30 [hp_X]/mL
  • XANTHIUM STRUMARIUM POLLEN30 [hp_X]/mL
  • LEUCANTHEMUM VULGARE POLLEN30 [hp_X]/mL
  • TARAXACUM OFFICINALE POLLEN30 [hp_X]/mL
  • LONICERA JAPONICA FLOWER30 [hp_X]/mL
  • IVA ANNUA POLLEN30 [hp_X]/mL
  • ARTEMISIA VULGARIS POLLEN30 [hp_X]/mL
  • AMARANTHUS RETROFLEXUS POLLEN30 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]

Package NDCNDC-11Package
58264-0317-15826403170129.57 mL in 1 BOTTLE, GLASS (58264-0317-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58264-0317 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0317 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58264-0317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.